Nov 11, 2016 13:00 pm UTC| Business
IN THE UNITED STATES DISTRICT COURTFOR THE WESTERN DISTRICT OF TEXASAUSTIN DIVISION KB PARTNERS I, LP Individually andon Behalf of All Other Similarly Situated, Plaintiff, v. PAIN THERAPEUTICS, INC., REMI BARBIER,...
CHMP issues positive opinion recommending Suliqua(TM) (iGlarLixi) for approval in the EU
Nov 11, 2016 12:52 pm UTC| Business
Company announcement - No. 44/2016 CHMP issues positive opinion recommending Suliqua(TM) (iGlarLixi) for approval in the EU Positive opinion based on data from two Phase III studies, LixiLan-O and LixiLan-LFinal...
Nov 11, 2016 12:30 pm UTC| Business
CRANBURY, N.J., Nov. 11, 2016 -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of rare and orphan diseases, today announced that data from the pivotal Phase 3 Study 012 (ATTRACT)...
GeneNews Announces Q3-2016 Financial Results and Provides Corporate Update
Nov 11, 2016 12:30 pm UTC| Business
TORONTO, Nov. 11, 2016 -- GeneNews Limited (TSX:GEN) (“GeneNews” or the “Company”) today reported operational and financial results for the three-month period ended September 30, 2016. Corporate Update The third...
Nov 11, 2016 12:30 pm UTC| Business
Phase 1 AXAL and durvalumab combination trial shows safety and tolerability in cervical and HPV+ head and neck cancerPreclinical data demonstrate synergistic antitumor effects of AXAL combined with a CD137 agonistic...
Nov 11, 2016 12:18 pm UTC| Business
NEW YORK, Nov. 11, 2016 -- AmTrust Financial Services, Inc. (Nasdaq:AFSI) (the “Company” or “AmTrust”) today announced that it has finalized its quarterly report on Form 10-Q for the third quarter 2016 and will submit...
BioSig Technologies To Present Today At The Emerging Medical Technologies Summit
Nov 11, 2016 12:15 pm UTC| Business
Minneapolis, MN, Nov. 11, 2016 -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a novel cardiac electrophysiology (EP) signal acquisition and analysis system, today...